Pfizer
Tracked across 69 events · 1655 articles · First seen Mar 25, 2025 · Last active Aug 20, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Pfizer India partnered with Cipla to expand the reach of its medicines across India, while continuing to manufacture and supply the four brands involved in the agreement.
Dec 19, 2025 · 6 articles
Business
Impact: The departure of its CFO, David Denton, for an opportunity outside the pharmaceutical industry, and the appointment of Cécile Guégan as interim CFO, has led to a slight decrease in Pfizer's stock price.
Jun 18, 2026 · 17 articles
Tech
Impact: The expanded approval of HYMPAVZI by the United States — Food and Drug Administration>>> is a significant positive development for Pfizer>>>, enhancing its product portfolio and market reach in the hemophilia treatment space. This approval is expected to boost Pfizer>>>'s revenue and solidify its position as a leader in rare disease therapies.
Jun 08, 2026 · 7 articles
Business
Impact: Pfizer temporarily discontinued Premarin cream in India due to supply challenges, with no material financial impact expected.
Jul 16, 2026 · 6 articles
Regulatory
Impact: Pfizer is the applicant seeking FDA approval for its drug combination; positive regulatory news may support revenue growth.
Jul 22, 2026 · 6 articles
Regulatory
The European Union — European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) for PF-07307405, a 6-valent OspA-based Lyme disease vaccine candidate co-developed by Pfizer and Valneva SE. The validation allows the EMA…
Impact: Pfizer is the lead developer and would exclusively manufacture and commercialize the vaccine if approved. The EMA validation advances its pipeline and could provide a new revenue stream.
Aug 14, 2026 · 12 articles
Tech
Impact: Pfizer is a pharmaceutical company developing a new Lyme disease vaccine, which has shown 70-75% effectiveness in late-stage studies. The company plans to seek regulatory approval, which could significantly boost its market position in infectious disease prevention.
Apr 30, 2026 · 24 articles
Tech
Impact: Pfizer manufactures the RSVpreF vaccine, which has shown significant effectiveness in preventing RSV-associated hospitalizations in infants. This positive real-world data validates their product and could lead to increased sales and market share in the vaccine segment.
Jun 05, 2026 · 7 articles
Regulatory
Impact: Pfizer had previously struck a deal with the administration to rein in prices and expects United States — Medicaid discounts to result in price and margin compression next year.
Dec 19, 2025 · 7 articles
Tech
Impact: Pfizer, through its Senior Director Neil Patel, provided a positive testimonial for Dataiku Cobuild, indicating potential benefits for the pharmaceutical industry in AI adoption.
Jun 11, 2026 · 6 articles
Tech
Impact: Pfizer executives are participating in the summit, contributing to discussions on AI adoption and its impact on business cases.
Jun 18, 2026 · 7 articles
Domestic
Impact: Pfizer's COVID-19 vaccine (with BioNTech) may see reduced demand in Germany; the company has faced scrutiny over adverse event data.
Jul 13, 2026 · 6 articles
Business
Impact: Pfizer participated in the symposium, aligning with industry trends toward sustainable pharmaceutical manufacturing.
Jul 20, 2026 · 6 articles
Tech
A Cornell University-led research group, led by Ciaran Seath, published a study in Nature Chemical Biology on August 13, 2026, describing a photochemically driven proximity labeling technique called MicroMap (µMap) to map protein-protein interactions in…
Impact: Contributed to the research, potentially gaining early access to a novel therapeutic target for cancer drug development.
Aug 13, 2026 · 6 articles
Tech
Impact: Pfizer has implemented digital manufacturing programs that leverage AI and data-driven systems to improve efficiency and operational performance, demonstrating a broader industry commitment to intelligent manufacturing.
Apr 07, 2026 · 8 articles
Regulatory
Impact: Pfizer previously signed a deal with the administration regarding drug pricing and co-developed Xtandi with Astellas Pharma.
Apr 20, 2026 · 6 articles
International
Impact: CEO Albert Bourla joined the AI for Good Global Commission.
Apr 20, 2026 · 123 articles
Domestic
Senator Rand Paul released the diary of Dr. Anthony Fauci, former director of the Norway — Norwegian Institute of Public Health, covering the COVID-19 pandemic. The diary reveals Fauci's private notes contradicting his public statements…
Impact: Mentioned as vaccine manufacturer; no direct impact from diary release.
Jul 29, 2026 · 13 articles
Business
Impact: Pfizer is referenced as a historical comparator, having attempted a hostile takeover of AstraZeneca in 2014. The current talks evoke memories of that failed bid.
Aug 02, 2026 · 60 articles
Regulatory
On August 5, 2026, the U.S. United States — Food and Drug Administration (FDA) approved Moderna's mFLUSIVA (mRNA-1010), the first mRNA-based seasonal influenza vaccine, for adults aged 50 and older. The approval covers traditional approval…
Impact: Pfizer, a rival in mRNA vaccines, may face competitive pressure as Moderna expands its mRNA platform into flu.
Aug 05, 2026 · 105 articles
Domestic
Republican Senators Ron Johnson and Rand Paul released a batch of text messages from Dr. Anthony Fauci's government-issued phone, showing discussions in January 2021 among Fauci, CDC Director Rochelle Walensky, and Surgeon General nominee Vivek…
Impact: One of the vaccine manufacturers; the controversy may slightly affect public perception, but no direct impact.
Aug 06, 2026 · 17 articles
Regulatory
Impact: Pfizer previously agreed to lower the cost of prescription drugs for United States — Medicaid following an executive order, setting a precedent for the current deal with Eli Lilly and Company and Novo Nordisk.
Nov 06, 2025 · 6 articles
Domestic
Impact: Pfizer's Abrysvo is mentioned as the only approved RSV vaccine for use in pregnancy, indicating its market position in this specific vaccine category.
Jun 10, 2026 · 6 articles
Accidents
Impact: The building is the former Pfizer headquarters; the event does not directly affect Pfizer's operations.
Jul 07, 2026 · 52 articles
Business
Impact: Pfizer's RSV vaccine Abrysvo faces increased competition from Moderna's mRESVIA in the EU market.
Jul 09, 2026 · 6 articles
Business
Impact: Pfizer's Litfulo is a competitor JAK inhibitor; positive bempikibart data may affect its market position.
Jul 13, 2026 · 6 articles
Business
Impact: Former Pfizer CMO Freda Lewis-Hall's advisory role provides a connection to Pfizer, but Pfizer itself is not directly affected.
Jul 22, 2026 · 6 articles
Business
Impact: Pfizer is a customer deploying Freehand's AI agents to manage supply chain spend.
Jul 29, 2026 · 6 articles
Tech
Impact: Pfizer has a collaboration agreement with Nurix, but this event does not directly affect that program.
Aug 04, 2026 · 6 articles
Regulatory
Impact: Pfizer supported Gilead's appeal, gaining from the precedent that protects pharmaceutical innovation.
Aug 03, 2026 · 6 articles
+ 39 more events
View on Dashboard
90
European Union — European Medicines Agency accepted application PfizerEMA validates...
80
Pfizer announced validationEMA validates...
45
Pfizer reported upbeat resultsAI earnings drive record...
20
Pfizer received approval United States — Food and Drug AdministrationEMA validates...
10
Andrew T. Chan served as consultant PfizerSugary Drinks Linked to...
ERGEN INTELLIGENCE
Track Pfizer live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard